Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Neuroendocrine Tumors

cabergoline has been researched along with Neuroendocrine Tumors in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Han, C; Lin, S; Lou, X; Wu, ZB1
Culler, MD; de Herder, WW; Dogan-Oruc, F; Feelders, RA; Herrera-Martínez, AD; Hofland, LJ; Luque, RM; van den Dungen, R; van Koetsveld, PM1
Albiger, N; Ceccato, F; Lombardi, G; Mazzai, L; Pambuku, A; Rolma, G; Scaroni, C; Zagonel, V1
Borson-Chazot, F; Ilie, MD; Raverot, G; Raverot, V; Tronc, F; Vasiljevic, A1
Bodei, L; Colao, A; de Herder, WW; de Krijger, RR; Faggiano, A; Ferone, D; Hofland, LJ; Lamberts, SW; Lombardi, G; Pivonello, R1

Other Studies

5 other study(ies) available for cabergoline and Neuroendocrine Tumors

ArticleYear
Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adult; Cabergoline; Ergolines; Humans; Hydroxychloroquine; Lactotrophs; Male; Neuroendocrine Tumors; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult

2022
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
    Endocrine-related cancer, 2019, Volume: 26, Issue:6

    Topics: Antineoplastic Agents, Hormonal; Cabergoline; Cell Culture Techniques; Cell Proliferation; Chromogranin A; Dopamine; Dopamine Agonists; Humans; Neuroendocrine Tumors; Octreotide; Receptors, Dopamine; Receptors, Somatostatin; Serotonin; Somatostatin; Spheroids, Cellular; Tumor Cells, Cultured

2019
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor.
    Anti-cancer drugs, 2019, Volume: 30, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Cabergoline; Combined Modality Therapy; Cytoreduction Surgical Procedures; Dopamine Agonists; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pituitary Neoplasms; Prognosis; Temozolomide

2019
Cabergoline in severe ectopic or occult Cushing's syndrome.
    European journal of endocrinology, 2019, Jul-01, Volume: 181, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adult; Aged; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Dopamine Agonists; Female; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Intraductal Neoplasms; Rectal Neoplasms; Steroid Synthesis Inhibitors; Thymus Neoplasms; Treatment Outcome

2019
Dopamine receptor expression and function in corticotroph ectopic tumors.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Cabergoline; Ergolines; Female; Humans; Hydrocortisone; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Receptors, Dopamine; Reverse Transcriptase Polymerase Chain Reaction; Thymus Neoplasms

2007